About
Pricing
FAQs
Providers
Trials
Blog
Developers
Back to your record
Login
Get started
Finding studies
Search
Narrow
Order
Status
Recruiting
Not yet recruiting
Active, not recruiting
Enrolling by invitation
Completed
Terminated
Phase
Early phase 1
Phase 1
Phase 1–2
Phase 2
Phase 2–3
Phase 3
Phase 4
Not applicable
Who can join
Healthy volunteers too
Searching
1–20 of 16,879
Active not recruiting
STEMVAC in Patients With Early Stage Triple Negative Breast Cancer
This phase II trial studies the effect of DNA plasmid based vaccine (STEMVAC) in treating patients with patients with stage IB-III triple negative breast cancer.
NCT05455658
·
Baltimore, Maryland and 2 others
·
University of Washington
Not yet recruiting
Effectiveness of a Multimodal Outpatient Supervised Physical Activity Program to Improve Tolerance and Efficacy of Chemotherapy in Adults With Breast, Lung and Colon Cancer
This clinical study evaluates whether a supervised, multimodal therapeutic exercise program started before chemotherapy and continued during treatment can improve treatment outcome…
NCT07502963
·
Vic, Barcelona and 2 others
·
University of Vic - Central University of Catalonia
Completed
Chemotherapy in Treating Patients With Solid Tumors
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.
NCT00003103
·
New York, New York
·
Memorial Sloan Kettering Cancer Center
Withdrawn
Study of Immunochemotherapy +/- Hypofractionated Radiation for Complete Response in Solid Tumors
The purpose of this study is to use Immunochemotherapy +/- Hypofractionated Radiation for complete response in solid tumors
NCT01936961
·
Goodyear, Arizona
·
Western Regional Medical Center
Recruiting
A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types
The primary objectives of the study are: (1) in the dose-escalation part: to evaluate safety and tolerability and to determine the recommended Phase 2 dose (RP2D) of farletuzumab e…
NCT04300556
·
Tucson, Arizona and 57 others
·
Eisai Inc.
Completed
A Study With ABBV-155 Alone and in Combination With Taxane Therapy in Adults With Relapsed and/or Refractory Solid Tumors
An open-label, dose-escalation (Part 1), dose-expansion (Part 2) study to assess the safety, pharmacokinetics (PK), and preliminary efficacy of ABBV-155 alone and in combination wi…
NCT03595059
·
Birmingham, Alabama and 39 others
·
AbbVie
Completed
A Tissue Collection Study in Patients Who Respond to Immune Checkpoint Inhibitors to Identify Targets of Tumor-Reactive T Cells.
T Cell Receptor-engineered T-cell therapy (TCR T-cell therapy) offers a potentially transformative approach to treating cancer, but is currently limited by the lack of known target…
NCT05230186
·
Los Angeles, California and 3 others
·
TScan Therapeutics, Inc.
Completed
G1T48, an Oral SERD, Alone and in Combination With Palbociclib in ER-Positive, HER2-Negative Advanced Breast Cancer
This is a study to investigate the potential clinical benefit of G1T48 as an oral selective estrogen receptor degrader (SERD) alone and in combination with palbociclib, a cyclin de…
NCT03455270
·
Beverly Hills, California and 14 others
·
G1 Therapeutics, Inc.
Recruiting
Trop-2 Targeted PET Probes in Advanced TNBC
According to inclusion and exclusion criteria, 20 eligible subjects with triple-negative breast cancer (TNBC) scheduled to receive sacituzumab govitecan were screened.
NCT07046455
·
Beijing
·
Peking University Cancer Hospital & Institute
Completed
A Double-blind Study of Paclitaxel in Combination With Reparixin or Placebo for Metastatic Triple-Negative Breast Cancer
The Objectives of this study: The primary objective of the study was to evaluate progression-free survival (PFS) (defined as the number of days between the date of randomization a…
NCT02370238
·
Mobile, Alabama and 76 others
·
Dompé Farmaceutici S.p.A
Not yet recruiting
Evaluation of Quality of Life After Facial Hyaluroic Acid Injections Following Treatment for Breast Cancer.
Breast cancer, the most common cancer in women, is increasingly managed as a chronic disease thanks to therapeutic advances.
NCT07425548
·
Institut Bergonié
Terminated
Nab-paclitaxel in Metastatic Breast Cancer Patients Failing Solvent Based Taxane (Tiffany)
Nab-paclitaxel has demonstrated to be an active agent in breast cancer and probably a less toxic alternative to solvent based taxanes.
NCT01416558
·
Neu-Isenburg
·
GBG Forschungs GmbH
Recruiting
Dalpiciclib in HR+/HER2- ABC
To evaluate the efficacy and safety of dalpiciclib in patients with HR-positive/HER2-positive advanced breast cancer.
NCT06301438
·
Shanghai
·
RenJi Hospital
Unknown
Assessing Breast Density's Value in Imaging - A Comparative Effectiveness Study
This Breast Cancer Surveillance Consortium (BCSC) ADVANCE study is a large, observational pragmatic comparative effectiveness research study using high-quality, prospectively colle…
NCT02980848
·
Davis, California and 6 others
·
University of California, Davis
Completed
Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility
Comparative study of two information modalities during the care course, aiming to propose the preservation of fertility to young women with breast cancer (but not yet under treatme…
NCT03591848
·
Clamart
·
Assistance Publique - Hôpitaux de Paris
Unknown
Prospective Screening and Differentiating Common Cancers Using Peripheral Blood Cell-Free DNA Sequencing
The goal of this observational study is to screen and differentiate common cancers in participants with or without suspicious lesions.
NCT06036563
·
Guangzhou, Guangdong and 7 others
·
Air Force Military Medical University, China
Withdrawn
The Effects of Pre-operative Physical Therapy Education
It is expected that patients who receive physical therapy before surgery will have greater range of motion (ROM), strength, function, satisfaction, and less swelling, pain, and anx…
NCT01669187
·
Saginaw, Michigan and 1 other
·
Oakland University
Unknown
Breast Cancer in Pregnancy Register Study
Women who were diagnosed with breast cancer during their pregnancy may be registered in this trial.
NCT00196833
·
Neu-Isenburg, Hesse
·
GBG Forschungs GmbH
Recruiting
Remotely-Delivered Cognitive Behavioral Stress Management for Breast Cancer (R-CBSM)
The purpose of this research study to find out if a program called Remotely-delivered Cognitive Behavioral Stress Management (R-CBSM) can help women with breast cancer in the perio…
NCT07502352
·
Coral Gables, Florida
·
University of Miami
Completed
Effectiveness of Ultrasound Guided Erector Spinae Plane Block Against Ultrasound Guided Serratus Anterior Block in Modified Radical Mastectomy
The aim of this study is to compare and evaluate the safety and analgesic efficacy of ultrasound guided ESP block and ultrasound guided serratus anterior plane block in patients un…
NCT04606147
·
Cairo
·
National Cancer Institute, Egypt
Back
1
2
3
···
844
1 / 844
Next
Data from
ClinicalTrials.gov
Terms